SCHEMBL4301530

SCHEMBL4301530

C=CCc1cc(C(C)C)cc(O)c(=O)c1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.40
GABRB2 P47870 4/20 0.40
XDH P47989 1/20 0.38
KDM4E B2RXH2 2/20 0.38
RNASEH1 O60930 1/20 0.37
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
POLB P06746 3/20 0.36
TYR P14679 2/20 0.36
SRD5A1 P18405 1/20 0.35
MAPK1 P28482 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 2/20 0.34
HPGD P15428 2/20 0.34
GAA P10253 1/20 0.33
MDM4 O15151 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4303199 0.85 XDH (0.37) GABRA1GABRB2XDHKDM4ERNASEH1
SCHEMBL4314977 0.81 TYR (0.46) GABRA1GABRB2XDHKDM4ERNASEH1
SCHEMBL26521877 0.79 GABRA1 (0.52) GABRA1GABRB2XDHKDM4ECYP1A2
SCHEMBL9908791 0.79 PTGS1 (0.45) GABRA1GABRB2XDHKDM4EMEN1
SCHEMBL4235975 0.78 KDM4E (0.39) GABRA1GABRB2XDHKDM4EMEN1
SCHEMBL9816379 0.73 GABRA1 (0.59) GABRA1GABRB2XDHKDM4ERNASEH1
SCHEMBL9028982 0.73 XDH (0.49) GABRA1GABRB2XDHKDM4ERNASEH1
SCHEMBL9248515 0.73 GABRA1 (0.40) GABRA1GABRB2XDHKDM4EMEN1
SCHEMBL9202213 0.73 AKR1B1 (0.60) GABRA1GABRB2MEN1KMT2APOLB
SCHEMBL7937251 0.71 PTGS2 (0.49) GABRA1GABRB2KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090081134-A1 Oral Care Compositions Comprising Tropolone Compounds and Essential Oils and Methods of Using The Same PAN PAULINE 2009-03-26 US disclosed
US-6924398-B2 Substituted tropolone compounds, oral care compositions containing the same and methods of using the same WARNER-LAMBERT COMPANY LLC (US) 2005-08-02 US disclosed
EP-1536759-A1 ORAL CARE COMPOSITION COMPRISING TROPOLONE COMPOUNDS AND ESSENTIAL OILS Warner-Lambert Company LLC (US) 2005-06-08 EP disclosed
US-20040204501-A1 Substituted tropolone compounds, oral care compositions containing the same and methods of using the same CHENANGO ZERO LLC 2004-10-14 US disclosed
US-20040185010-A1 Oral care compositions comprising tropolone compounds and essential oils and methods of using the same MCNEIL-PPC, INC 2004-09-23 US disclosed
US-6787675-B2 CHEMICAL STABILITY; SOLUBILITY; KILLING PATHOGENIC MICROORGANISMS RESPONSIBLE FOR ODOR, PLAQUE AND GINGIVITIS; MOUTHWASHES, RINSES WARNER-LAMBERT COMPANY 2004-09-07 US disclosed
WO-2004012692-A1 ORAL CARE COMPOSITION COMPRISING TROPOLONE COMPOUNDS AND ESSENTIAL OILS WARNER-LAMBERT COMPANY LLC (US) 2004-02-12 WO disclosed
US-6689342-B1 DENTISTRY WARNER-LAMBERT COMPANY 2004-02-10 US disclosed
US-20040018216-A1 Substituted tropolone compounds, oral care compositions containing the same and methods of using the same JOHNSON & JOHNSON CONSUMER INC. 2004-01-29 US disclosed
US-20040018154-A1 ORAL CARE COMPOSITIONS COMPRISING TROPOLONE COMPOUNDS AND ESSENTIAL OILS AND METHODS OF USING THE SAME MCNEIL-PPC, INC 2004-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090081134-A1 Oral Care Compositions Comprising Tropolone Compounds and Essential Oils and Methods of Using The Same TMSB10, PIGS, TPM3 GABRA1 2641/4885GABRB2 3843/4885XDH 1078/4885
US-20040185010-A1 Oral care compositions comprising tropolone compounds and essential oils and methods of using the same TMSB10, PIGS, TPM3 GABRA1 2641/4885GABRB2 3843/4885XDH 1078/4885
US-20040018216-A1 Substituted tropolone compounds, oral care compositions containing the same and methods of using the same TPM3, TPM4, TMSB10 GABRA1 2326/4885GABRB2 3239/4885XDH 625/4885
US-20040204501-A1 Substituted tropolone compounds, oral care compositions containing the same and methods of using the same TPM3, TPM4, TMSB10 GABRA1 2326/4885GABRB2 3239/4885XDH 625/4885
US-20040018154-A1 ORAL CARE COMPOSITIONS COMPRISING TROPOLONE COMPOUNDS AND ESSENTIAL OILS AND METHODS OF USING THE SAME TMSB10, PIGS, TPM3 GABRA1 2641/4885GABRB2 3843/4885XDH 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.